NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $74.40 -0.01 (-0.02%) Closing price 03:59 PM EasternExtended Trading$72.86 -1.54 (-2.07%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solventum alerts:Sign Up Key Stats Today's Range$73.67▼$75.2350-Day Range$62.49▼$75.1052-Week Range$62.38▼$88.20Volume1.79 million shsAverage Volume1.28 million shsMarket Capitalization$12.88 billionP/E Ratio9.12Dividend YieldN/APrice Target$83.36Consensus RatingHold Company Overview Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 60% of companies evaluated by MarketBeat, and ranked 303rd out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingSolventum has received a consensus rating of Hold. The company's average rating score is 2.46, and is based on no strong buy ratings, 7 buy ratings, 5 hold ratings, and 1 sell rating.Upside PotentialSolventum has a consensus price target of $83.36, representing about 12.1% upside from its current price of $74.40.Amount of Analyst CoverageSolventum has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth6.99% Earnings GrowthEarnings for Solventum are expected to grow by 6.99% in the coming year, from $6.58 to $7.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 9.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.34.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 9.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.87.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.75% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 6.42.Change versus previous monthShort interest in Solventum has recently increased by 1.58%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.41 News SentimentSolventum has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Solventum this week, compared to 6 articles on an average week.Search Interest8 people have searched for SOLV on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days.MarketBeat Follows5 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,344.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.24% of the stock of Solventum is held by insiders.Percentage Held by InstitutionsSolventum has minimal institutional ownership at this time.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SOLV Stock News HeadlinesSolventum Foundation and America's ToothFairy Launch National Effort to Expand Access to Preventive Dental CareMay 14 at 2:24 PM | finance.yahoo.comSolventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13 at 4:03 PM | seekingalpha.comFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 14 at 1:00 AM | Porter & Company (Ad)Is It Time To Reassess Solventum (SOLV) After Its Recent Share Price Rebound?May 12 at 7:35 AM | uk.finance.yahoo.comWhy Solventum (SOLV) Is Up 8.8% After Beating Adjusted Q1 Estimates And Reaffirming 2026 OutlookMay 12 at 7:35 AM | uk.finance.yahoo.comSolventum to Participate in the 2026 BofA Securities Health Care ConferenceMay 7, 2026 | prnewswire.comSolventum (NYSE:SOLV) Receives "Buy" Rating from BTIG ResearchMay 7, 2026 | americanbankingnews.comSolventum outlines EPS toward high end of $6.40-$6.60 range while expecting $100M-$120M annual tariff headwindsMay 6, 2026 | seekingalpha.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $79.25 at the beginning of the year. Since then, SOLV stock has decreased by 6.1% and is now trading at $74.3970. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) released its quarterly earnings data on Tuesday, May, 5th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.35 by $0.13. The company's quarterly revenue was down 3.0% on a year-over-year basis. Read the conference call transcript. How will Solventum's stock buyback program work? Solventum's board approved a stock buyback plan on Thursday, November 20th 2025, which authorizes the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 7.5% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its stock is undervalued. Who are Solventum's major shareholders? Solventum's top institutional shareholders include Arrowstreet Capital Limited Partnership (0.51%), Bank of New York Mellon Corp (0.45%), Dimensional Fund Advisors LP (0.45%) and KBC Group NV (0.36%). View institutional ownership trends. How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings5/05/2026Today5/14/2026AGM 20265/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 SOLV's financial health is in the Red zone, according to TradeSmith. SOLV has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees20,000Year Founded2023Price Target and Rating Average Price Target for Solventum$83.36 High Price Target$103.00 Low Price Target$50.00 Potential Upside/Downside+12.1%Consensus RatingHold Rating Score (0-4)2.46 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$8.16 Trailing P/E Ratio9.12 Forward P/E Ratio11.31 P/E Growth1.16Net Income$1.56 billion Net Margins17.33% Pretax Margin20.47% Return on Equity23.51% Return on Assets7.63% Debt Debt-to-Equity Ratio0.96 Current Ratio1.07 Quick Ratio0.75 Sales & Book Value Annual Sales$8.26 billion Price / Sales1.56 Cash Flow$8.90 per share Price / Cash Flow8.36 Book Value$28.69 per share Price / Book2.59Miscellaneous Outstanding Shares173,175,000Free Float172,759,000Market Cap$12.88 billion OptionableOptionable Beta0.59 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:SOLV) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredNeedle-free peptide delivery and a $294 billion market aheadA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWhat Expenses Can Be Deducted From Capital Gains Tax This Year?Capital gains taxes can quietly erode investment returns - but the tax code offers legitimate ways to potentia...SmartAsset | SponsoredDistracted Americans set to miss out on quadrillionsTechnology expert and Washington D.C. insider Jeff Brown - who identified Bitcoin, Tesla, and Nvidia early - s...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
